Ligand validation:5XAN

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 5XAN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5XAN_OLC_B_803	34%	77%	0.181	0.946	0.29	0.6	-	-	0	0	56%	0.56
5XAN_OLC_B_801	33%	53%	0.209	0.916	0.98	0.83	1	-	0	0	84%	0.84
5XAN_OLC_A_803	28%	71%	0.165	0.927	0.42	0.66	-	-	0	0	40%	0.4
5XAN_OLC_B_802	23%	51%	0.235	0.861	1.05	0.85	1	1	3	0	100%	1
5XAN_OLC_A_802	22%	82%	0.186	0.921	0.31	0.49	-	-	0	0	32%	0.32
5XAN_OLC_A_804	21%	82%	0.182	0.875	0.26	0.54	-	-	1	0	52%	0.52
5XAN_OLC_B_804	14%	85%	0.232	0.916	0.41	0.33	-	-	0	0	24%	0.24
5XAN_OLC_A_801	13%	69%	0.249	0.896	0.3	0.88	-	-	0	0	40%	0.4
5XAN_OLC_B_805	7%	89%	0.256	0.853	0.36	0.29	-	-	0	0	20%	0.2
5XAP_OLC_A_807	34%	80%	0.185	0.941	0.22	0.6	-	-	1	0	60%	0.6
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.